Primary tabs
Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.
Revision | Operations | |
---|---|---|
02-13-25 by ripal121 | current revision | |
02-7-25 by ripal121 ripal121 replaced Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module. | ||
02-7-25 by ripal121 ripal121 replaced Intermittent HD with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module. | ||
02-7-25 by conan.macdougal... [email protected] replaced For detailed view of dialysis dosing and evidence, see <a href="https://idmp.ucsfsitebuilder.acsitefactory.com/content/ucsf-adult-antimicrobial-dosing-dialysis-reference-document">Dosing in Hemodialysis</a> document.</p> with via Scanner Search and Replace module. | ||
02-4-25 by ripal121 | ||
12-10-24 by ripal121 | ||
12-10-24 by ripal121 | ||
11-26-24 by ripal121 | ||
11-26-24 by ripal121 | ||
11-26-24 by ripal121 | ||
11-25-24 by ripal121 | ||
11-25-24 by ripal121 |
Dosing: Adult Antimicrobial Dosing, Non-dialysis
Indication | Dose | Notes |
---|---|---|
Pneumocystis pneumonia (PROPHYLAXIS) |
100 mg PO Q24H |
Use in patients who are intolerant of sulfa No renal adjustment Rule out G6PD deficiency prior to treatment initiation Dapsone monotherapy does not provide prophylaxis for Toxoplasmosis |
Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis
Indication | Dose | Notes |
---|---|---|
Pneumocystis pneumonia (PROPHYLAXIS) |
100 mg PO Q24H |
Use in patients who are intolerant of sulfa No renal adjustment Rule out G6PD deficiency prior to treatment initiation Dapsone monotherapy does not provide prophylaxis for Toxoplasmosis |